1Allen DA,Breen C, Yaqoob MM, et al. Inhibition of CFU-E colony formarion in uremic patients with inflammatory disease : role of IFN-gamma and TNF-alpha. J Investig Med, 1999,47(5) ,204 - 11.
2Goicoechea M, Martin J, de-Sequera P, et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int, 1998, 54(4), 1337 - 43.
3Navarro JF, Mora C, Garcia J, et al. Effects Pentoxifylline on the haematologic status in anaemic patients with advaced renal failure. Scand J Urol Nephrol, 1999,33(2), 121-5.
4Dybedad Y, Larsen S, Jacobsen SEW. IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor . J Immunol , 1995,154,4950 - 4955.
5Sanchez MC, Bajo MA, Selgas R, et al. Cultures of human osteoblastic cells from dialysis patients: influence of bone turnover rate on in vitro selection of interleukin-6 and osteoblastic cell makers. Am J Kidney Dis,2001,37(1) ,30- 37.
6Takayama F, Miyazaki T, Aoyama I, et al. Involement of interleukin-8 in dialysis-related arthritis. Kidney Int, 1998,53(4), 1007 - 13.
7Libetta C, Rampino T, Dal-Canton A. Polarization of Thelper lymphocytes toward the Th2 phenotype in uremic patients.Am J Kidney Dis,2001,38(2),286- 95.
8Skoutelis AT, Kaleridis VE, Goumenos DS, et al. Polymorphonuclear leukocyte rigidity is defective in patiems with chronic renal failure.Nephrol Dial Transplant ,2000,15(11) ,1788-93.
9Gimdt M, Kaul H, Leitnaker CK, et al. Selective sequestration of cytokineproducing monocytes during hemodialysis treatment. Am J Kidney Dis,2001.37(5).954 - 63.
10Pecoits-Filho R, Barany P,Lindholm B,et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment . Nephrol Dial Transplant,2002,17(9), 1684 - 8.
